Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? - Wikidata - thesis-toulmin - TriplyDB

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

http://www.wikidata.org/entity/Q36970702

about

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression Evaluation of eicosanoids in nasal lavage as biomarkers of inflammation in patients with allergic rhinitis.Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis.TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1.Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.Fibrosis in systemic sclerosis: common and unique pathobiology.PTEN directly activates the actin depolymerization factor cofilin-1 during PGE2-mediated inhibition of phagocytosis of fungi Prostanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities.Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking The cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis.BLT1 Mediates Bleomycin-Induced Lung Fibrosis Independently of Neutrophils and CD4+ T Cells.Prostaglandin E2's new trick: "decider" of differential alveolar cell life and death.Simultaneously Targeting Myofibroblast Contractility and Extracellular Matrix Cross-Linking as a Therapeutic Concept in Airway Fibrosis.Update in diffuse parenchymal lung disease 2008.The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.Improvement in spirometry and oxygenation of chronic obstructive pulmonary disease during pregnancy

P2860

Q24627446-40559418-A5FD-48F0-BC4B-97A8A3D60B80 Q30420291-BA18FC86-5D87-4620-BE29-DE854C506217 Q30582046-603BB8C4-F0CB-4C74-8507-1B138B97FC21 Q33761334-1D11DA74-1C7B-4898-8BEF-AFDE38F5CF0F Q33765936-4D1CDC79-0D5D-464A-ACED-02CF7AB389A6 Q34776159-A9A481CB-07B1-4EC0-977E-FEB63980A0C7 Q34992980-A2F02195-E16C-4F5F-B099-0C440CBB10D3 Q35009383-B40336B7-85C8-467C-93A5-BA6407F8CE23 Q35501630-74144375-C75C-4F4E-BF53-F9B250DFC097 Q36012572-70798FF0-5F12-4BE8-87CB-8D4EE8569275 Q36104685-F5115847-5678-4598-80D5-C783CA96EAFD Q36243240-7A7CD739-DA30-4CE8-84FF-1B98F2A1BBBB Q37418337-3F0A7EC1-2CE6-420C-8C8E-5C7D4A5BC776 Q37638268-97D886F9-E3E7-481D-9B17-70D4E1C8FC43 Q37721063-F0E91B0F-8573-4CD1-AE0C-E1F257A42237 Q37794776-E5CE3C21-C0A2-4C3D-8C9B-1343DD6AED96 Q37941508-921B4008-71F7-4D59-82ED-55091A34DD86 Q40385076-ADBF04AB-BE82-4AD0-AD93-AA2B3713C39F Q42986655-8DDA3DF0-70E6-4B88-AAD7-663EAF423FE9 Q48037448-CC576699-C6BB-46D1-B3E9-E680862687BF Q51782313-6C33A1D0-0E8A-4B15-B711-99F81BF586FC Q52332667-697F96F7-58A0-42D6-9631-B9BC18540969 Q58776626-23FB0946-69E5-4CFF-AA6A-3C6A55FD8B56

P2860

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

http://www.wikidata.org/entity/Q36970702

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

@en

type

label

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

@en

prefLabel

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

@en

P1433

Q36970702-11E92F0E-5EF9-488A-8F1E-C0D5C843E20B

P1476

Q36970702-1736F0A0-2110-4336-B395-0966FADF344B

P2093

Q36970702-3CFFC9D8-CF15-4116-B96D-CB5A8794F711

P2860

Q36970702-036B5F33-96AC-4B2E-896E-4DAA098D64B4

Q36970702-1C32D0E9-8853-44CE-A556-595490BABFBC

Q36970702-267FF1DF-CF3D-4D43-8670-145AC2B7AD2F

Q36970702-2EF97B40-DE6A-4346-9633-2719BE62A9E6

Q36970702-3987E2A3-C1C5-4F58-88D5-C73CBBCF9354

Q36970702-3C7AA22D-9C89-4786-A802-E942CF6E0683

Q36970702-42310963-BF9C-4CB2-8DF3-F8DB4D5F8AA3

Q36970702-43DB472A-A684-4A64-B73C-1CADB1889406

Q36970702-4511890A-B845-44AE-9797-735EF305BD08

Q36970702-456B39BE-6499-4721-A062-FD113B5E5D18

P304

Q36970702-A1CC9F85-E302-42CB-B9C9-45D46E12AE53

P31

Q36970702-7562CCCD-491B-4530-9737-1D1164CBF20B

P356

Q36970702-468503C1-9A19-460B-B7DD-82508A2B7CCA

P407

Q36970702-754AC6C9-C45E-4F4A-ACF3-D5E7E14B08F1

P433

Q36970702-DB0F084E-33C9-4C4E-8179-672C2F322AB9

P478

Q36970702-2752F835-E008-4476-81A4-590E34469D75

P50

Q36970702-3AA3ADF3-BFAE-4C55-9B68-7A8D8B2EC559

P577

Q36970702-274F5559-F89F-48B3-B79F-DE2AE299E2E0

P5875

Q36970702-710DB183-199A-4EF9-B675-3979EF27BE0F

P698

Q36970702-F30D8D56-EF2E-482F-955B-DDF921285EA2

P932

Q36970702-DE65CE21-6828-4DBF-A734-CABDB9407505

P356

P1433

P1476

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

@en

P2093

Steven K Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells

Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4

Prostaglandins and leukotrienes: advances in eicosanoid biology

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice

Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling.

Prostaglandin E(2) regulates wound closure in airway epithelium.

PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling.

P304

1442-1450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.08-0306

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Marc Peters-Golden

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5280613

http://www.w3.org/2001/XMLSchema#string

P698

18574287

http://www.w3.org/2001/XMLSchema#string

P932

2582216

http://www.w3.org/2001/XMLSchema#string